ATM and familial pancreatic carcinoma: In line with our current results, Shindo et al. recently reported that among 27 patients with pancreatic cancer harboring pathogenic germline mutations in BRCA1/BRCA2/ATM/PALB2, only three patients (11.1%) had a family history of pancreatic cancer [14].